Avery Telehealth's Chronic Care Management (CCM) service is designed to deliver personalized, proactive care for patients managing chronic conditions. Our comprehensive approach ensures better health outcomes and improved patient engagement through the following key features:

• Disease-Specific Pathways & Protocols: Utilizes evidence-based pathways tailored to each chronic condition, ensuring precise and effective care plans.
• Dynamic Care Adjustments: Adapts care strategies based on patient acuity and condition progression for optimal outcomes.
• Vital Tracking & Trending: Monitors patient vitals in real-time, allowing clinicians to identify health trends and intervene early if needed.
• Medication Adherence Monitoring: Ensures patients remain on track with their prescribed treatments, reducing the risk of complications.
• Patient Education & Empowerment: Provides educational resources and tools to help patients actively participate in their care and manage their conditions confidently.

With Avery Telehealth's CCM service, healthcare providers can reduce hospital readmissions, enhance clinical operations, and deliver higher-quality care that prioritizes the well-being of their patients.

Avery Telehealth offers comprehensive telehealth solutions tailored for healthcare providers, organizations, and consumers, specializing in remote patient monitoring and readmission avoidance programs. Our full-service platform integrates connected health devices, customizable health programs, and digital health solutions to enhance patient engagement, streamline clinical operations, and improve health outcomes.

The Propeller Digital Therapeutic Platform

Propeller’s FDA-cleared digital therapeutic platform consists of Bluetooth-enabled sensors, a digital patient experience through mobile app or web portal, a clinician insights portal for remote monitoring, plus tailored patient support through virtual coaching. These components seamlessly integrate with one another to improve health outcomes for patients, and in turn, drive measurable clinical and business outcomes for healthcare organizations. Here’s how it works:

1. PropellerConnect™ Sensors & Data Connectivity: Propeller sensors capture unique signals that passively record events, such as medication usage or respiration, and transmit data to Propeller via Bluetooth or hub connection. Sensors are compatible with more than 80% of inhaled medications on the U.S. market, including medications for MDI, Respimat®, Diskus®, Ellipta®, and Symbicort® inhalers.*
2. MyPropeller™ Patient App & Portal: Sensor data is sent to the Propeller mobile app or online portal, empowering patients to learn about their breathing and triggers while delivering personalized, motivating journeys that build healthy habits.
3. PropellerInsight™ Clinical Decision Support & Analytics: Via an EHR integration or our Clinician Portal, care teams can remotely monitor patients’ medication use and view on-demand reports to gain a clearer understanding of disease control status, symptoms, and triggers. These insights help inform clinical decisions and treatment plans, and enable proactive identification of patients who may be at a greater risk for an exacerbation and require timely clinical intervention.
4. PropellerCare™ Support and Coaching: Propeller’s patient success team ensures users receive personalized support and coaching to help them confidently navigate the platform, stay focused on their goals, and take control of their breathing.

Propeller Health Solutions

Propeller configures its digital therapeutic platform into a variety of solutions that help healthcare and life sciences organizations meet their goals while navigating the shift to value-based care.

• For Independent Physician Groups: Remote therapeutic monitoring programs to enhance care for eligible chronic patients
• For Hospitals and Health Systems: Digital health programs for select clinics, target populations, or systemwide; integration into a service line/specialty for population health management
• For Payers and Pharmacy Benefits Managers: Integration of digital health programs into existing care management or population health initiatives
• For Life Sciences Organizations: Integration or co-packaging of digital companion (i.e., sensor, app, support) with connected drug delivery devices such as inhalers to support clinical trials, medication adherence, and biologics

---

*Respimat is a registered trademark of Boehringer Ingelheim Pharmaceuticals, Inc. Diskus and Ellipta are registered trademarks of the GlaxoSmithKline group of companies. Symbicort is a registered trademark of the AstraZeneca group of companies.

Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. We power motivating, care-connected patient journeys and unify value for all stakeholders – providers, health systems, payers, pharmaceutical companies, and other healthcare and life sciences organizations.

The Propeller Platform includes FDA-cleared and CE-marked medical devices, consumer apps, support, and secure access to clinical data for provider monitoring. Our precision approach motivates behavior change and tracks patient adherence that enables medication optimization, helping predict costly exacerbations. We set the scientific standard in digital-first chronic respiratory care through our peer-reviewed research demonstrating improved quality of life and clinical outcomes while lowering healthcare costs.

As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.

• Specialized for chronic care management with detailed protocols and pathways.
• Real-time vital tracking and trending for proactive care with actionable insights.
• Dynamic pathways that adjust based on patient acuity and condition progression.
• Seamless integration with a wide range of remote monitoring devices.
• Patient-focused tools to enhance self-management and engagement.
• Proactive monitoring to reduce hospital readmissions and improve outcomes.
• Quick implementation with intuitive interfaces for minimal disruption.

• Tailored Disease Pathways: Offers highly customized, evidence-based care pathways designed to manage specific chronic conditions, ensuring precision and effectiveness.
• Dynamic Adjustments Based on Acuity: Adapts care strategies based on patient acuity and condition progression, delivering a truly adaptive care model.
• Comprehensive Data Integration: Combines advanced vital tracking, trending, and medication adherence data for a holistic view of patient health.
• Patient-Centric Focus: Prioritizes patient education and empowerment, equipping patients with the knowledge and tools to actively manage their conditions.
• End-to-End Digital Health Solution: Seamlessly integrates with other services like Remote Patient Monitoring (RPM) and Readmission Avoidance programs, creating a unified ecosystem.
• Scalability & Flexibility: Supports organizations of all sizes, from small practices to large health systems, with solutions that scale effortlessly.
• Proven Impact on Health Outcomes: Demonstrates measurable improvements in patient outcomes, medication adherence, and reduced hospital readmissions through data-driven approaches.
• Streamlined Implementation & Usability: Designed for quick implementation and ease of use, ensuring minimal disruption for clinicians and patients.
• Integrated Care Across the Continuum: Bridges gaps between acute and chronic care for seamless transitions and continuity of patient management.

To learn about how Propeller differentiates from other options in this space, please reach out to info@propellerhealth.com. 

As a leading precision digital health company, Propeller Health differs from others in the industry in that:  

• Our 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market – and our capabilities go far beyond respiratory care.
• We have conducted 80+ commercial programs and research studies, and a body of research no other digital health company can match: more than 150 peer-reviewed publications and abstracts.
• Our parent company has decades of experience bringing specialized medical devices to market in more than 140 countries. Together, our regulatory expertise, logistics support, engineering and component sourcing knowledge is unmatched.
• We have unique experience partnering with and unifying value for stakeholders across the healthcare ecosystem: independent clinics, hospitals and health systems, payers and PBMs, pharmaceutical and life sciences companies, as well as patients and clinicians. 

---

Our FDA-cleared digital therapeutic platform stands apart from other digital health solutions in that: 

• It is used by a broad spectrum of patients from pediatric (asthma) to elderly (COPD), and is proven effective in engaging underserved and vulnerable patient populations (Medicaid, Medicare). 
• It engages patients with COPD — an often difficult to engage patient population — earlier in their care (stages 1 and 2). For patients whose conditions continue to progress, they can receive care in later stages (3 and 4) with solutions from our parent company, ResMed.